Indiva Announces Amendment and Expansion to Licence and Provides Corporate Update
New space facilitates additional production capacity for top-performing edibles
LONDON, Ontario – March 31, 2020: Today, Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF) is announcing that Health Canada has approved its licence amendment, adding 10,000 square feet of production space. The newly licensed space adds additional capacity for production of Bhang® Chocolate, Wana Sour Gummies and other Powered by INDIVA™ products. It also provides licensed space for Indiva to begin extraction operations. With the receipt of this amendment, Indiva’s London, Ontario-based facility is now fully licensed.
Indiva is also providing a corporate update on the Company’s market position, strategic partnerships and opportunity in 2020. On February 8, 2020, Bhang® Chocolate hit store shelves in Ontario. Within days, both the milk and dark chocolate ranked in the top two positions for sales, by dollars and units, above all other edible SKUs in the province, and received numerous glowing reviews on platforms like Lift&Co and on social media. Similarly, Bhang® Chocolate quickly became, and remains, a consumer favourite in Alberta, Saskatchewan and Nova Scotia. Across the four provinces where Bhang® is currently available, the Company has secured significant market share within the edibles category. In Q2 2020, Indiva intends to expand distribution of Bhang® Chocolate to British Columbia and beyond. The Company is excited to extend its reach by bringing Bhang® to more provinces and increasing its Canadian market share.
“While we are exceptionally pleased with Bhang® Chocolate’s performance, the real story behind its success is the team that has worked so hard to bring this beloved product to market,” Niel Marotta, President and Chief Executive Officer, said. “Indiva’s roots are defined by its people, products and partnerships, and we are proud of the passion that goes into every item that leaves our facility. We expect to enter new markets and deliver new, innovative products that already have significant market share in mature markets south of the border. Canadians want great cannabis products at competitive prices. Our partnerships with proven, trusted brands help us deliver just that, and we cannot wait to share our next great product with consumers – Wana Sour Gummies.”
In addition to releasing Bhang® Chocolate this year, Indiva also launched THC capsules and continues to produce its whole flower pre-rolls in classic strains such as White Russian, Jack Herer and OG Kush. Indiva expects to triple its capacity to produce pre-rolls, with the introduction of best-in-class automation in Q2 2020, and has entered into contract cultivation agreements to support higher volumes. Indiva products are currently available in six provinces, including the following:
- Ontario: pre-rolls, chocolate and capsules
- Alberta: chocolate
- Saskatchewan: pre-rolls, chocolate and capsules
- Nova Scotia: chocolate
Looking ahead, Indiva is excited to deliver Wana Brands’ award-winning Sour Gummies later this year to Canadians in flavours like strawberry lemonade, pomegranate blueberry acai and watermelon and in a variety of CBD/THC formats. Wana Sour Gummies are vegan, gluten-free and are made without artificial flavours and sugars making them a favourite in the markets where they are available. Wana Brands is the leading edible producer in the United States with more dollars sold than any other brand according to BDS Analytics’ 2019 Brand Share Report.
It’s difficult to provide an update without addressing COVID-19 and its impact. The Company puts the highest importance on the safety of its employees and has evolved protocols and made investments to protect their health. This support has been crucial to maintaining business continuity during the recent global pandemic. Indiva’s leadership will continue to monitor the situation and evolve practices as needed based on guidance from provincial and federal authorities. With the cannabis industry being labeled as an essential service across Canada, Indiva continues to grow and provide Canadians with high-quality products like chocolate, pre-rolls and capsules. Indiva is also still hiring across many departments and encourages interested individuals to visit www.indiva.com/careers to learn more.
Indiva will present its year-end 2019 fiscal results by April 29, 2020, and its Q1 2020 results by June 1, 2020.
About Indiva
Indiva sets the standard for quality and innovation in cannabis. As a Canadian licensed producer, Indiva creates premium pre-rolls, flower, capsules, oils, and edible products and provides production, manufacturing and refinement services to peer entities. In Canada, Indiva produces and distributes the award-winning Bhang® Chocolate, Wana Sour Gummies, Ruby® Cannabis Sugar, Sapphire™ Cannabis Salt, Gems™, and other Powered by INDIVA™ products through license agreements, partnerships and joint ventures. Click here to connect with Indiva on LinkedIn, Instagram, Twitter and Facebook, and here to find more information on the Company and its products.
Media Contact
Kate Abernathy
Vice President of Communications
Phone: 613-296-5764
Email: [email protected]
Investor Contact
Steve Low
Investor Relations
Phone: 647-620-5101
Email: [email protected]
Disclaimer and Reader Advisory
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the contents of this press release and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the Company’s future operations, future product offerings and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the Company. The material factors and assumptions include the Company being able to maintain the necessary regulatory and other third parties’ approvals and licensing and other risks associated with regulated entities in the cannabis industry. The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.